speb/financial-data huggingface dataset:
LUNG balance_sheet (quarterly, 2025-09-30) — Capital Stock: 41000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 76549000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 76549000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Cash Equivalents: 3509000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Cash Financial: 73040000.00
LUNG cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 181000.00
LUNG cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 8711000.00
LUNG cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -8162000.00
LUNG cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 121000.00
LUNG cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 528000.00
LUNG cash_flow (quarterly, 2025-09-30) — Change In Income Tax Payable: -7000.00
LUNG cash_flow (quarterly, 2025-09-30) — Change In Inventory: -1021000.00
LUNG cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 122000.00
LUNG cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -381000.00
LUNG cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 13000.00
LUNG cash_flow (quarterly, 2025-09-30) — Change In Payable: 114000.00
LUNG cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 642000.00
LUNG cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -913000.00
LUNG cash_flow (quarterly, 2025-09-30) — Change In Receivables: 1410000.00
LUNG cash_flow (quarterly, 2025-09-30) — Change In Tax Payable: -7000.00
LUNG cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -128000.00
LUNG cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 1410000.00
LUNG cash_flow (quarterly, 2025-09-30) — Changes In Cash: 730000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Common Stock: 41000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 60033000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 44000.00
LUNG income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 5450000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 9751000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Current Assets: 111235000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 1136000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Current Debt: 105000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1241000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 92000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 92000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 22878000.00
LUNG cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 246000.00
LUNG cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 246000.00
LUNG income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 40936896.00
LUNG income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.34
LUNG income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -13957000.00
LUNG income_statement (quarterly, 2025-09-30) — EBIT: -13024000.00
LUNG income_statement (quarterly, 2025-09-30) — EBITDA: -12778000.00
LUNG cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 355000.00
LUNG cash_flow (quarterly, 2025-09-30) — End Cash Position: 76810000.00
LUNG cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 181000.00
LUNG cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -8251000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 2238000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Goodwill: 2333000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 2333000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 13897000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Gross PPE: 27280000.00
LUNG income_statement (quarterly, 2025-09-30) — Gross Profit: 16052000.00
LUNG cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 150000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 189000.00
LUNG income_statement (quarterly, 2025-09-30) — Interest Expense: 805000.00
LUNG income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 805000.00
LUNG income_statement (quarterly, 2025-09-30) — Interest Income: 611000.00
LUNG income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 611000.00
LUNG cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 792000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Inventory: 16248000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Invested Capital: 97163000.00
LUNG cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 8711000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Leases: 2336000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 18298000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 37025000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 55323000.00
LUNG cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -1000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 6621000.00
LUNG income_statement (quarterly, 2025-09-30) — Net Income: -13957000.00
LUNG income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -13957000.00
LUNG income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -13957000.00
LUNG income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -13957000.00
LUNG income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -13957000.00
LUNG cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -13957000.00
LUNG income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -13957000.00
LUNG income_statement (quarterly, 2025-09-30) — Net Interest Income: -194000.00
LUNG cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 8800000.00
LUNG cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -1000.00
LUNG cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -1000.00
LUNG income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -194000.00
LUNG cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -23000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Net PPE: 20722000.00
LUNG cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -89000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 57700000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 47000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 47000.00
LUNG income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -12778000.00
LUNG income_statement (quarterly, 2025-09-30) — Normalized Income: -13957000.00
LUNG cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -8162000.00
LUNG income_statement (quarterly, 2025-09-30) — Operating Income: -14393000.00
LUNG income_statement (quarterly, 2025-09-30) — Operating Revenue: 21502000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 41246534.00
LUNG balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 129000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 105000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 2238000.00
LUNG income_statement (quarterly, 2025-09-30) — Other Income Expense: 758000.00
LUNG cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 479000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 3991000.00
LUNG income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 758000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Other Properties: 18279000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 0.00
LUNG balance_sheet (quarterly, 2025-09-30) — Payables: 7529000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 17280000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 4265000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
LUNG balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 3752000.00
LUNG income_statement (quarterly, 2025-09-30) — Pretax Income: -13829000.00
LUNG cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 205000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
LUNG cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 0.00
LUNG cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: 0.00
LUNG cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -89000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Receivables: 14296000.00
LUNG income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 5450000.00
LUNG income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 246000.00
LUNG cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -1000.00
LUNG income_statement (quarterly, 2025-09-30) — Research And Development: 4846000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 261000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -511133000.00
LUNG cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 8800000.00
LUNG income_statement (quarterly, 2025-09-30) — Selling General And Administration: 25599000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Share Issued: 41246534.00
LUNG cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 5166000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 60033000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 57700000.00
LUNG income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
LUNG income_statement (quarterly, 2025-09-30) — Tax Provision: 128000.00
LUNG income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
LUNG balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 499000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Total Assets: 138281000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 97058000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Total Debt: 56564000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 60033000.00
LUNG income_statement (quarterly, 2025-09-30) — Total Expenses: 35895000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 78248000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 27046000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 55370000.00
LUNG income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -14393000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 1109000.00
LUNG balance_sheet (quarterly, 2025-09-30) — Working Capital: 88357000.00
LUNG income_statement (annual, 2025-12-31) — +Operating Expense: 120802000.00
LUNG income_statement (quarterly, 2025-12-31) — +Operating Expense: 27444000.00
LUNG income_statement (annual, 2025-12-31) — +Total Revenue: 90497000.00
LUNG income_statement (quarterly, 2025-12-31) — +Total Revenue: 22598000.00
LUNG balance_sheet (annual, 2025-12-31) — Accounts Payable: 3905000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 3905000.00
LUNG balance_sheet (annual, 2025-12-31) — Accounts Receivable: 12072000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 12072000.00
LUNG balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -6650000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -6650000.00
LUNG balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 573272000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 573272000.00
LUNG balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -100000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -100000.00
LUNG cash_flow (annual, 2025-12-31) — Amortization Of Securities: -379000.00
LUNG cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: 0.00
LUNG cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 143000.00
LUNG cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 167000.00
LUNG income_statement (annual, 2025-12-31) — Basic Average Shares: 40685934.00
LUNG income_statement (quarterly, 2025-12-31) — Basic Average Shares: 41403844.00
LUNG income_statement (annual, 2025-12-31) — Basic EPS: -1.33
LUNG income_statement (quarterly, 2025-12-31) — Basic EPS: -0.25
LUNG cash_flow (annual, 2025-12-31) — Beginning Cash Position: 71162000.00
LUNG cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 76810000.00
LUNG cash_flow (annual, 2025-12-31) — Capital Expenditure: -452000.00
LUNG cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -13000.00
LUNG balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 19269000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 19269000.00
LUNG balance_sheet (annual, 2025-12-31) — Capital Stock: 42000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Capital Stock: 42000.00
LUNG balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 69751000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 69751000.00
LUNG balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 69751000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 69751000.00
LUNG balance_sheet (annual, 2025-12-31) — Cash Equivalents: 1038000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 1038000.00
LUNG balance_sheet (annual, 2025-12-31) — Cash Financial: 68713000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Cash Financial: 68713000.00
LUNG cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 833000.00
LUNG cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 55000.00
LUNG cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 30482000.00
LUNG cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -13000.00
LUNG cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -32376000.00
LUNG cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -7084000.00
LUNG cash_flow (annual, 2025-12-31) — Change In Account Payable: 270000.00
LUNG cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -2496000.00
LUNG cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -2279000.00
LUNG cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -443000.00
LUNG cash_flow (annual, 2025-12-31) — Change In Income Tax Payable: 194000.00
LUNG cash_flow (quarterly, 2025-12-31) — Change In Income Tax Payable: 109000.00
LUNG cash_flow (annual, 2025-12-31) — Change In Inventory: -765000.00
LUNG cash_flow (quarterly, 2025-12-31) — Change In Inventory: -810000.00
LUNG cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -142000.00
LUNG cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 95000.00
LUNG cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -955000.00
LUNG cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -281000.00
LUNG cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -136000.00
LUNG cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -88000.00
LUNG cash_flow (annual, 2025-12-31) — Change In Payable: 464000.00
LUNG cash_flow (quarterly, 2025-12-31) — Change In Payable: -2387000.00
LUNG cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -1815000.00
LUNG cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -2830000.00
LUNG cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 813000.00
LUNG cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 627000.00
LUNG cash_flow (annual, 2025-12-31) — Change In Receivables: 1075000.00
LUNG cash_flow (quarterly, 2025-12-31) — Change In Receivables: 1606000.00
LUNG cash_flow (annual, 2025-12-31) — Change In Tax Payable: 194000.00
LUNG cash_flow (quarterly, 2025-12-31) — Change In Tax Payable: 109000.00
LUNG cash_flow (annual, 2025-12-31) — Change In Working Capital: -1925000.00
LUNG cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -1681000.00
LUNG cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 1075000.00
LUNG cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 1606000.00
LUNG cash_flow (annual, 2025-12-31) — Changes In Cash: -1061000.00
LUNG cash_flow (quarterly, 2025-12-31) — Changes In Cash: -7042000.00
LUNG balance_sheet (annual, 2025-12-31) — Common Stock: 42000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Common Stock: 42000.00
LUNG balance_sheet (annual, 2025-12-31) — Common Stock Equity: 54116000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 54116000.00
LUNG balance_sheet (annual, 2025-12-31) — Construction In Progress: 51000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 51000.00
LUNG income_statement (annual, 2025-12-31) — Cost Of Revenue: 23358000.00
LUNG income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 5057000.00
LUNG balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 9996000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 9996000.00
LUNG balance_sheet (annual, 2025-12-31) — Current Assets: 101684000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Current Assets: 101684000.00
LUNG balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 1210000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 1210000.00
LUNG balance_sheet (annual, 2025-12-31) — Current Debt: 106000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Current Debt: 106000.00
LUNG balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 1316000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1316000.00
LUNG balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 18000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 18000.00
LUNG balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 18000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 18000.00
LUNG balance_sheet (annual, 2025-12-31) — Current Liabilities: 20058000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 20058000.00
LUNG cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 1054000.00
LUNG cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 231000.00
LUNG cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 1054000.00
LUNG cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 231000.00
LUNG income_statement (annual, 2025-12-31) — Diluted Average Shares: 40685934.00
LUNG income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 41403844.00
LUNG income_statement (annual, 2025-12-31) — Diluted EPS: -1.33
LUNG income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.25
LUNG income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -54003000.00
LUNG income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -10425000.00
LUNG income_statement (annual, 2025-12-31) — EBIT: -50222000.00
LUNG income_statement (quarterly, 2025-12-31) — EBIT: -9469000.00
LUNG income_statement (annual, 2025-12-31) — EBITDA: -49168000.00
LUNG income_statement (quarterly, 2025-12-31) — EBITDA: -9238000.00
LUNG cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -92000.00
LUNG cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 241000.00
LUNG cash_flow (annual, 2025-12-31) — End Cash Position: 70009000.00
LUNG cash_flow (quarterly, 2025-12-31) — End Cash Position: 70009000.00
LUNG cash_flow (annual, 2025-12-31) — Financing Cash Flow: 833000.00
LUNG cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 55000.00
LUNG cash_flow (annual, 2025-12-31) — Free Cash Flow: -32828000.00
LUNG cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -7097000.00
LUNG balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 2360000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 2360000.00
LUNG balance_sheet (annual, 2025-12-31) — Goodwill: 2333000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Goodwill: 2333000.00
LUNG balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 2333000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 2333000.00
LUNG balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 12172000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 12172000.00
LUNG balance_sheet (annual, 2025-12-31) — Gross PPE: 26898000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Gross PPE: 26898000.00
LUNG income_statement (annual, 2025-12-31) — Gross Profit: 67139000.00
LUNG income_statement (quarterly, 2025-12-31) — Gross Profit: 17541000.00
LUNG cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 468000.00
LUNG cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 104000.00
LUNG balance_sheet (annual, 2025-12-31) — Income Tax Payable: 263000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 263000.00
LUNG income_statement (annual, 2025-12-31) — Interest Expense: 3155000.00
LUNG income_statement (quarterly, 2025-12-31) — Interest Expense: 770000.00
LUNG income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 3155000.00
LUNG income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 770000.00
LUNG income_statement (annual, 2025-12-31) — Interest Income: 2651000.00
LUNG income_statement (quarterly, 2025-12-31) — Interest Income: 453000.00
LUNG income_statement (annual, 2025-12-31) — Interest Income Non Operating: 2651000.00
LUNG income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 453000.00
LUNG cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 3113000.00
LUNG cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 749000.00
LUNG balance_sheet (annual, 2025-12-31) — Inventory: 15845000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Inventory: 15845000.00
LUNG balance_sheet (annual, 2025-12-31) — Invested Capital: 91211000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Invested Capital: 91211000.00
LUNG cash_flow (annual, 2025-12-31) — Investing Cash Flow: 30482000.00
LUNG cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -13000.00
LUNG balance_sheet (annual, 2025-12-31) — Leases: 2336000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Leases: 2336000.00
LUNG balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 18059000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 18059000.00
LUNG balance_sheet (annual, 2025-12-31) — Long Term Debt: 36989000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 36989000.00
LUNG balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 55048000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 55048000.00
LUNG cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -100000.00
LUNG cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -51000.00
LUNG balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 6483000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 6483000.00
LUNG income_statement (annual, 2025-12-31) — Net Income: -54003000.00
LUNG income_statement (quarterly, 2025-12-31) — Net Income: -10425000.00
LUNG income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -54003000.00
LUNG income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -10425000.00
LUNG income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -54003000.00
LUNG income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -10425000.00
LUNG income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -54003000.00
LUNG income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -10425000.00
LUNG income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -54003000.00
LUNG income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -10425000.00
LUNG cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -54003000.00
LUNG cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -10425000.00
LUNG income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -54003000.00
LUNG income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -10425000.00
LUNG income_statement (annual, 2025-12-31) — Net Interest Income: -504000.00
LUNG income_statement (quarterly, 2025-12-31) — Net Interest Income: -317000.00
LUNG cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 30934000.00
LUNG cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 0.00
LUNG cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -100000.00
LUNG cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -51000.00
LUNG cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -100000.00
LUNG cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -51000.00
LUNG income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -504000.00
LUNG income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -317000.00
LUNG cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -70000.00
LUNG cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 0.00
LUNG balance_sheet (annual, 2025-12-31) — Net PPE: 20248000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Net PPE: 20248000.00
LUNG cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -452000.00
LUNG cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -13000.00
LUNG balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 51783000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 51783000.00
LUNG balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 69000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 69000.00
LUNG balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 69000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 69000.00
LUNG income_statement (annual, 2025-12-31) — Normalized EBITDA: -49168000.00
LUNG income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -9238000.00
LUNG income_statement (annual, 2025-12-31) — Normalized Income: -54003000.00
LUNG income_statement (quarterly, 2025-12-31) — Normalized Income: -10425000.00
LUNG cash_flow (annual, 2025-12-31) — Operating Cash Flow: -32376000.00
LUNG cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -7084000.00
LUNG income_statement (annual, 2025-12-31) — Operating Income: -53663000.00
LUNG income_statement (quarterly, 2025-12-31) — Operating Income: -9903000.00
LUNG income_statement (annual, 2025-12-31) — Operating Revenue: 90497000.00
LUNG income_statement (quarterly, 2025-12-31) — Operating Revenue: 22598000.00
LUNG balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 41673648.00
LUNG balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 41673648.00
LUNG balance_sheet (annual, 2025-12-31) — Other Current Assets: 491000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 491000.00
LUNG balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 106000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 106000.00
LUNG balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 2360000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 2360000.00
LUNG income_statement (annual, 2025-12-31) — Other Income Expense: 790000.00
LUNG income_statement (quarterly, 2025-12-31) — Other Income Expense: -19000.00
LUNG cash_flow (annual, 2025-12-31) — Other Non Cash Items: 1501000.00
LUNG cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 383000.00
LUNG balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 5026000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 5026000.00
LUNG income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 790000.00
LUNG income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -19000.00
LUNG balance_sheet (annual, 2025-12-31) — Other Properties: 18028000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Other Properties: 18028000.00
LUNG balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 0.00
LUNG balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 0.00
LUNG balance_sheet (annual, 2025-12-31) — Payables: 5179000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Payables: 5179000.00
LUNG balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 15175000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 15175000.00
LUNG balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 3549000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 3549000.00
LUNG balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
LUNG balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
LUNG balance_sheet (annual, 2025-12-31) — Prepaid Assets: 2676000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 2676000.00
LUNG income_statement (annual, 2025-12-31) — Pretax Income: -53377000.00
LUNG income_statement (quarterly, 2025-12-31) — Pretax Income: -10239000.00
LUNG cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 1003000.00
LUNG cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 106000.00
LUNG balance_sheet (annual, 2025-12-31) — Properties: 0.00
LUNG balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
LUNG cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 0.00
LUNG cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 0.00
LUNG cash_flow (annual, 2025-12-31) — Purchase Of Investment: -5651000.00
LUNG cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: 0.00
LUNG cash_flow (annual, 2025-12-31) — Purchase Of PPE: -452000.00
LUNG cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -13000.00
LUNG balance_sheet (annual, 2025-12-31) — Receivables: 12663000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Receivables: 12663000.00
LUNG income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 23358000.00
LUNG income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 5057000.00
LUNG income_statement (annual, 2025-12-31) — Reconciled Depreciation: 1054000.00
LUNG income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 231000.00
LUNG cash_flow (annual, 2025-12-31) — Repayment Of Debt: -100000.00
LUNG cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -51000.00
LUNG income_statement (annual, 2025-12-31) — Research And Development: 19491000.00
LUNG income_statement (quarterly, 2025-12-31) — Research And Development: 4583000.00
LUNG balance_sheet (annual, 2025-12-31) — Restricted Cash: 258000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 258000.00
LUNG balance_sheet (annual, 2025-12-31) — Retained Earnings: -521558000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -521558000.00
LUNG cash_flow (annual, 2025-12-31) — Sale Of Investment: 36585000.00
LUNG cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 0.00
LUNG income_statement (annual, 2025-12-31) — Selling General And Administration: 101311000.00
LUNG income_statement (quarterly, 2025-12-31) — Selling General And Administration: 22861000.00
LUNG balance_sheet (annual, 2025-12-31) — Share Issued: 41673648.00
LUNG balance_sheet (quarterly, 2025-12-31) — Share Issued: 41673648.00
LUNG cash_flow (annual, 2025-12-31) — Stock Based Compensation: 21233000.00
LUNG cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 4241000.00
LUNG balance_sheet (annual, 2025-12-31) — Stockholders Equity: 54116000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 54116000.00
LUNG balance_sheet (annual, 2025-12-31) — Tangible Book Value: 51783000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 51783000.00
LUNG income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
LUNG income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
LUNG income_statement (annual, 2025-12-31) — Tax Provision: 626000.00
LUNG income_statement (quarterly, 2025-12-31) — Tax Provision: 186000.00
LUNG income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
LUNG income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
LUNG balance_sheet (annual, 2025-12-31) — Taxes Receivable: 591000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 591000.00
LUNG balance_sheet (annual, 2025-12-31) — Total Assets: 129291000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Total Assets: 129291000.00
LUNG balance_sheet (annual, 2025-12-31) — Total Capitalization: 91105000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 91105000.00
LUNG balance_sheet (annual, 2025-12-31) — Total Debt: 56364000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Total Debt: 56364000.00
LUNG balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 54116000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 54116000.00
LUNG income_statement (annual, 2025-12-31) — Total Expenses: 144160000.00
LUNG income_statement (quarterly, 2025-12-31) — Total Expenses: 32501000.00
LUNG balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 75175000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 75175000.00
LUNG balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 27607000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 27607000.00
LUNG balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 55117000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 55117000.00
LUNG income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -53663000.00
LUNG income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -9903000.00
LUNG balance_sheet (annual, 2025-12-31) — Total Tax Payable: 1274000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 1274000.00
LUNG balance_sheet (annual, 2025-12-31) — Working Capital: 81626000.00
LUNG balance_sheet (quarterly, 2025-12-31) — Working Capital: 81626000.00
LUNG income_statement (quarterly, 2026-03-31) — +Operating Expense: 29000000.00
LUNG income_statement (quarterly, 2026-03-31) — +Total Revenue: 20586000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 3474000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 10830000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -6867000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 578762000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -100000.00
LUNG cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: 0.00
LUNG cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 144000.00
LUNG income_statement (quarterly, 2026-03-31) — Basic Average Shares: 41897669.00
LUNG income_statement (quarterly, 2026-03-31) — Basic EPS: -0.33
LUNG cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 70009000.00
LUNG cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -9000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 18980000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Capital Stock: 42000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 61572000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 61572000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 545000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Cash Financial: 61027000.00
LUNG cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 2026000.00
LUNG cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -9000.00
LUNG cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -10097000.00
LUNG cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -430000.00
LUNG cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -1165000.00
LUNG cash_flow (quarterly, 2026-03-31) — Change In Income Tax Payable: 51000.00
LUNG cash_flow (quarterly, 2026-03-31) — Change In Inventory: -959000.00
LUNG cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 61000.00
LUNG cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -329000.00
LUNG cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 18000.00
LUNG cash_flow (quarterly, 2026-03-31) — Change In Payable: -379000.00
LUNG cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -1544000.00
LUNG cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -29000.00
LUNG cash_flow (quarterly, 2026-03-31) — Change In Receivables: 1204000.00
LUNG cash_flow (quarterly, 2026-03-31) — Change In Tax Payable: 51000.00
LUNG cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -1578000.00
LUNG cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 1204000.00
LUNG cash_flow (quarterly, 2026-03-31) — Changes In Cash: -8080000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Common Stock: 42000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 45761000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 0.00
LUNG income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 4542000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 10148000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Current Assets: 92746000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 1239000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Current Debt: 104000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1343000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 32000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 32000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 18906000.00
LUNG cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 220000.00
LUNG cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 220000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 277000.00
LUNG income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 41897669.00
LUNG income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.33
LUNG income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -13654000.00
LUNG income_statement (quarterly, 2026-03-31) — EBIT: -12529000.00
LUNG income_statement (quarterly, 2026-03-31) — EBITDA: -12309000.00
LUNG cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -100000.00
LUNG cash_flow (quarterly, 2026-03-31) — End Cash Position: 61829000.00
LUNG cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 2026000.00
LUNG cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -10106000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 2169000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Goodwill: 2333000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 2333000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 10930000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Gross PPE: 26581000.00
LUNG income_statement (quarterly, 2026-03-31) — Gross Profit: 16044000.00
LUNG cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 76000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 329000.00
LUNG income_statement (quarterly, 2026-03-31) — Interest Expense: 976000.00
LUNG income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 976000.00
LUNG income_statement (quarterly, 2026-03-31) — Interest Income: 350000.00
LUNG income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 350000.00
LUNG cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 789000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Inventory: 16310000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Invested Capital: 83074000.00
LUNG cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -9000.00
LUNG cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 38785000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Leases: 2336000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 17741000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 37209000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 54950000.00
LUNG cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 38785000.00
LUNG cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -37000000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 6591000.00
LUNG income_statement (quarterly, 2026-03-31) — Net Income: -13654000.00
LUNG income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -13654000.00
LUNG income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -13654000.00
LUNG income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -13654000.00
LUNG income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -13654000.00
LUNG cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -13654000.00
LUNG income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -13654000.00
LUNG income_statement (quarterly, 2026-03-31) — Net Interest Income: -626000.00
LUNG cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 0.00
LUNG cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 1785000.00
LUNG cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 1785000.00
LUNG income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -626000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Net PPE: 19714000.00
LUNG cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -9000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 43428000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 72000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 72000.00
LUNG income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -12309000.00
LUNG income_statement (quarterly, 2026-03-31) — Normalized Income: -13654000.00
LUNG cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -10097000.00
LUNG cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 107000.00
LUNG income_statement (quarterly, 2026-03-31) — Operating Income: -12956000.00
LUNG income_statement (quarterly, 2026-03-31) — Operating Revenue: 20586000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 42237203.00
LUNG balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 44000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 104000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 2169000.00
LUNG income_statement (quarterly, 2026-03-31) — Other Income Expense: 77000.00
LUNG cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 528000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 5173000.00
LUNG income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 77000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Other Properties: 17654000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Payables: 4491000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 14639000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 2892000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
LUNG balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 3292000.00
LUNG income_statement (quarterly, 2026-03-31) — Pretax Income: -13505000.00
LUNG cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 241000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
LUNG cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: 0.00
LUNG cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -9000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Receivables: 11271000.00
LUNG income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 4542000.00
LUNG income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 220000.00
LUNG cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -37000000.00
LUNG income_statement (quarterly, 2026-03-31) — Research And Development: 4899000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 257000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -535212000.00
LUNG cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 0.00
LUNG income_statement (quarterly, 2026-03-31) — Selling General And Administration: 24101000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Share Issued: 42237203.00
LUNG cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 4136000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 45761000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 43428000.00
LUNG income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
LUNG income_statement (quarterly, 2026-03-31) — Tax Provision: 149000.00
LUNG income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
LUNG balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 441000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Total Assets: 119966000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 82970000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Total Debt: 56293000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 45761000.00
LUNG income_statement (quarterly, 2026-03-31) — Total Expenses: 33542000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 74205000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 27220000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 55299000.00
LUNG income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -12956000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 1017000.00
LUNG balance_sheet (quarterly, 2026-03-31) — Working Capital: 73840000.00
LUNR balance_sheet (annual, 2021-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
LUNR income_statement (annual, 2021-12-31) — Basic Average Shares: 18070265.00
LUNR income_statement (annual, 2021-12-31) — Basic EPS: -1.97
LUNR cash_flow (annual, 2021-12-31) — Change In Inventory: 0.00
LUNR cash_flow (annual, 2021-12-31) — Common Stock Issuance: 0.00
LUNR balance_sheet (annual, 2021-12-31) — Current Debt: 12108000.00
LUNR income_statement (annual, 2021-12-31) — Depreciation Income Statement: 840000.00